New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2013
15:23 EDTHOTT, DCTH, VRA, FTK, CWTR, MW, DBLE, BKEPCompanies reporting After the Market Close on Wednesday, March 13
Notable companies reporting after the closing bell on Wednesday include Blueknight Energy Partners (BKEP), Coldwater Creek (CWTR), Delcath Systems (DCTH), Double Eagle Petroleum (DBLE), Flotek Industries (FTK), Hot Topic (HOTT), Men's Wearhouse (MW), and Vera Bradley (VRA).
News For BKEP;CWTR;DCTH;DBLE;FTK;HOTT;MW;VRA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
09:43 EDTFTKFlotek mentioned cautiously in a Seeking Alpha article
Subscribe for More Information
July 28, 2015
10:07 EDTVRAHigh option volume stocks
Subscribe for More Information
July 27, 2015
17:03 EDTDCTHMitchell Kopin reports 6.7% passive stake in Delcath Systems
10:00 EDTFTKOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ADT Corp. (ADT) upgraded to Buy from Neutral at Citi... AGCO (AGCO) upgraded to Neutral from Sell at Goldman... Anthem (ANTM) upgraded to Buy from Neutral at Sterne Agee CRT... BNP Paribas (BNPQY) upgraded to Buy from Neutral at Goldman... Biogen (BIIB) upgraded on valuation at Bernstein... Box (BOX) upgraded to Overweight from Sector Weight at Pacific Crest... Capital One (COF) upgraded to Buy from Outperform at CLSA... Centene (CNC) upgraded to Buy from Neutral at UBS... Chesapeake (CHK) upgraded on potential sale of assets or company at SunTrust... Cigna (CI) upgraded to Buy from Neutral at Sterne Agee CRT... Deere (DE) upgraded to Neutral from Sell at Goldman... First BanCorp (FBP) upgraded to Buy from Neutral at Guggenheim... Flotek (FTK) upgraded on stronger demand at Oppenheimer... Lear (LEA) upgraded to Buy from Hold at Deutsche Bank... Methanex (MEOH) upgraded to Outperform from Sector Perform at Scotia Howard Weil... News Corp. (NWSA) upgraded to Outperform from Neutral at Macquarie... NextEra Energy Partners (NEP) upgraded to Outperform at Wells Fargo... OFG Bancorp (OFG) upgraded to Buy from Neutral at Guggenheim... PennyMac Mortgage (PMT) upgraded to Buy from Neutral at Compass Point... Pool Corp. (POOL) upgraded to Outperform from Market Perform at William Blair... Popular (BPOP) upgraded to Buy from Neutral at Guggenheim... Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley... Quality Systems (QSII) upgraded on valuation at RBC Capital... VF Corp. (VFC) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded on valuation, positive catalysts at BMO Capital... Weatherford (WFT) upgraded to Equal Weight from Underweight at Barclays... SS&C (SSNC) upgraded to Buy from Hold at Sandler O'Neill... Chemung Financial (CHMG) upgraded to Buy from Hold at Sandler O'Neill... Cameron (CAM) upgraded to Buy from Accumulate at Global Hunter.
08:03 EDTFTKFlotek upgraded on stronger demand at Oppenheimer
Subscribe for More Information
06:16 EDTFTKFlotek upgraded to Perform from Underperform at Oppenheimer
Subscribe for More Information
July 23, 2015
10:05 EDTFTKHigh option volume stocks
Subscribe for More Information
09:13 EDTFTKOn The Fly: Pre-market Movers
Subscribe for More Information
07:30 EDTFTKFlotek added to Best Ideas List at Stephens
Stephens added Flotek the the Best Ideas List citing the significant Q2 beat and believes Flotek can continue to grow even in a flat rig count environment . The firm rates Flotek an Overweight and increased its price target to $23 from $17 on shares.
July 22, 2015
16:23 EDTFTKFlotek sees profitable growth for 2H15
While we are very pleased with our second quarter results, we understand that cyclical headwinds remain which will continue to provide challenges to our industry in the coming months," concluded CEO Chisholm. "However, as our second quarter results show, a more difficult environment has created an opportunity for Flotek to demonstrate the importance of performance adding technology in maximizing operator performance and, as a result new opportunities for Flotek's advanced chemistry technologies. Through the use of FracMax and the 'Flotek Store', we believe the third quarter should build on the success of the last three months and provide opportunities for profitable growth in the second half of the year."
16:22 EDTFTKFlotek reports Q2 adjusted EPS 2c, consensus (7c)
Subscribe for More Information
July 20, 2015
08:07 EDTDCTHDelcath Systems's melphalan granted Orphan Drug Designation by FDA
Delcath Systems announced that the FDA Office of Orphan Products Development, or OOPD, has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma. The OOPD is tasked with evaluating the scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to further advance scientific development of such promising medical products.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use